Documentary explores dementia using decayed film
The makers of a new documentary have used decayed 16mm film to represent "what dementia might feel like inside the mind". The ...
Nottinghamshire Live on MSN3h
Millions of Brits at risk of dementia due to common sleep disorder - the red flags to look out for
A common sleep disorder that affects millions of Brits can raise your risk of dementia, according to health experts ...
Hosted on MSN11h
Early signs of dementia that may be seen before memory loss
a common brain disorder causing damage to human brain cells. Dementia in recent times has become very common as damage to ...
PharmiWeb1h
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease
Eisai Europe Ltd. and Biogen Inc. announced today that a positive opinion has been received from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...
JCN Newswire3h
Nationwide TV Commercial Launched in Japan to Raise Awareness About MCI (Mild Cognitive Impairment)
TOKYO, Nov 15, 2024 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Japan Ltd announced today that a TV commercial will be ...
cambridgeindependent5h
Glaucoma drug shows promise in fight against neurodegenerative diseases, say University of Cambridge experts
A drug used to treat glaucoma holds promise in the fight against various forms of dementia, according to University of ...
GlobalData on MSN16h
EMA rethinks stance, committee now recommends Leqembi for Alzheimer’s disease
Following a re-evaluation, the EMA has recommended Eisai and Biogen’s Alzheimer’s therapy Leqembi for a subgroup of patients.
EMA recommends Leqembi for treatment of early Alzheimer’s disease
After re-examining its initial opinion, EMA’s human medicines committee, or CHMP, has recommended granting a marketing authorisation to Leqembi for treating mild cognitive impairment or mild dementia ...
Ottawa Citizen on MSN3hOpinion
Frank: Here's why we should prioritize Alzheimer's treatment
As Canada’s population ages, the incidence of dementia due to Alzheimer’s disease is on the rise. There are currently more ...
‘The Unicorn' at UNTHSC is a gamechanger, say Alzheimer's researchers
Researchers say ‘the Unicorn,’ their invention at the University of Texas Health Science Center, is a game-changer in the ...
Firefly Neuroscience, Inc.: Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update
Company successfully listed on Nasdaq under the symbol "AIFF" Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company's du ...
FiercePharma19h
EMA changes tune, endorses Eisai and Biogen's Leqembi in restricted Alzheimer's population
Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | ...